Eloxx Pharmaceuticals Inc (ELOX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2001 | 12-2000 | 06-2000 | 12-1999 | 06-1999 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10 | 1,550 | 1,550 | 940 | 940 |
| Other current assets | 20 | 10 | 10 | 10 | 10 |
| TOTAL | $30 | $1,560 | $1,560 | $950 | $950 |
| Non-Current Assets | |||||
| PPE Net | 70 | 70 | 70 | 70 | 70 |
| Other Non-Current Assets | 157 | 100 | 100 | 50 | 50 |
| TOTAL | $227 | $170 | $170 | $120 | $120 |
| Total Assets | $270 | $1,740 | $1,740 | $1,080 | $1,080 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 160 | 210 | 210 | 170 | 170 |
| Accrued Expenses | 260 | 0 | 0 | 3 | 3 |
| Other current liabilities | 0 | 10 | 10 | 0 | 0 |
| TOTAL | $430 | $220 | $220 | $170 | $170 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 40 | 0 | 0 | 0 | 0 |
| TOTAL | $40 | $N/A | $0 | $N/A | $0 |
| Total Liabilities | $480 | $220 | $220 | $170 | $170 |
| Shareholders' Equity | |||||
| Common Shares | 70 | 70 | 70 | 5 | 5 |
| Retained earnings | -5,490 | -3,610 | -3,610 | -1,160 | -1,160 |
| Other shareholders' equity | -240 | -180 | -180 | -5 | -5 |
| TOTAL | $-200 | $1,510 | $1,510 | $910 | $910 |
| Total Liabilities And Equity | $280 | $1,730 | $1,730 | $1,080 | $1,080 |